secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mersana Therapeutics, Inc. (—)
CIK:        0001442836
Form:       8-K
Filed at:   2025-02-28T23:59:59+00:00
Accession:  0001104659-25-019146
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Mersana Therapeutics receives Nasdaq delisting notice for bid price non-compliance
--------------------------------------------------------------------------------

- Notice on Feb 25, 2025 for failure to maintain $1.00 minimum bid for 30 consecutive business days.
- Company has 180 days (until Aug 25, 2025) to regain compliance by closing bid >=$1.00 for 10 consecutive days.
- If not compliant, may get second 180-day period by moving to Nasdaq Capital Market and considering reverse stock split.
- No immediate effect on listing or trading of MRSN common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1442836/000110465925019146/0001104659-25-019146-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1442836/000110465925019146/tm257819d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-019146

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer